Clinical Study
Tricuspid Valve Regurgitation after Orthotopic Heart Transplantation: Prevalence and Etiology
Table 4
Clinical outcomes of late significant (at least mild-moderate) TR.
| Clinical outcome | No TR/mild TR () | At least mild-moderate TR () | value |
| Mortality (% patients) | 28.6% | 47.8% | 0.065 | Median serum creatinine at the end of followup (mg/dL)* | 1.4 (0.5–10.4) | 1.8 (1.0–2.9) | 0.081 | Need for diuretic therapy ≥ 10 mg furosemide/day (% patients) | 10.4% | 47.1% | <0.001 | Need for another heart surgery | 1.7% | 33.3% | <0.001 |
|
|
TR: tricuspid regurgitation.
*
Data are presented as median and range (min–max).
|